Ksouri, A.;                     Klouz, A.;                     Bouhaouala-Zahar, B.;                     Moussa, F.;                     Bezzarga, M.    
        Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2. Molecules 2023, 28, 4296.
    https://doi.org/10.3390/molecules28114296
    AMA Style
    
                                Ksouri A,                                 Klouz A,                                 Bouhaouala-Zahar B,                                 Moussa F,                                 Bezzarga M.        
                Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2. Molecules. 2023; 28(11):4296.
        https://doi.org/10.3390/molecules28114296
    
    Chicago/Turabian Style
    
                                Ksouri, Ayoub,                                 Anis Klouz,                                 Balkiss Bouhaouala-Zahar,                                 Fathi Moussa,                                 and Mounir Bezzarga.        
                2023. "Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2" Molecules 28, no. 11: 4296.
        https://doi.org/10.3390/molecules28114296
    
    APA Style
    
                                Ksouri, A.,                                 Klouz, A.,                                 Bouhaouala-Zahar, B.,                                 Moussa, F.,                                 & Bezzarga, M.        
        
        (2023). Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2. Molecules, 28(11), 4296.
        https://doi.org/10.3390/molecules28114296